Cargando…

AP4M1 as a prognostic biomarker associated with cell proliferation, migration and immune regulation in hepatocellular carcinoma

BACKGROUND: AP4M1 is a protein-coding gene that plays a crucial role in transporter activity, recognition, and hereditary-associated diseases, but it’s largely unknown in cancers. METHODS: The expression level of AP4M1 in cancers was investigated by The Cancer Genome Atlas (TCGA) and Gene Expression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Yuanhao, Li, Xuanxuan, Kang, Kuo, Zhou, Yangying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568912/ https://www.ncbi.nlm.nih.gov/pubmed/37821948 http://dx.doi.org/10.1186/s12935-023-03089-0

Ejemplares similares

Comprehensive analysis of the expression profile and clinical implications of regulator of chromosome condensation 2 in pan-cancers
por: Li, Xuanxuan, et al.
Publicado: (2022)

RAD51AP1 as an Immune-Related Prognostic Biomarker and Therapeutic Response Predictor in Hepatocellular Carcinoma
por: Wei, Yongguang, et al.
Publicado: (2023)

Identification and validation of a tyrosine metabolism-related prognostic prediction model and characterization of the tumor microenvironment infiltration in hepatocellular carcinoma
por: Zhou, Yangying, et al.
Publicado: (2022)

PRELP has prognostic value and regulates cell proliferation and migration in hepatocellular carcinoma
por: Hong, Runqi, et al.
Publicado: (2020)

An m6A-Related Prognostic Biomarker Associated With the Hepatocellular Carcinoma Immune Microenvironment
por: Du, Yingxi, et al.
Publicado: (2021)

Neuraminidase 1 (NEU1) promotes proliferation and migration as a diagnostic and prognostic biomarker of hepatocellular carcinoma
por: Hou, Guojun, et al.
Publicado: (2016)

The deubiquitinase EIF3H promotes hepatocellular carcinoma progression by stabilizing OGT and inhibiting ferroptosis
por: Tang, Jianing, et al.
Publicado: (2023)

PAX1 hypomethylation as a prognostic biomarker for radioresistance of cervical cancer
por: Li, Xuanxuan, et al.
Publicado: (2023)

CDK2AP1 influences immune infiltrates and serves as a prognostic indicator for hepatocellular carcinoma
por: Che, Yibin, et al.
Publicado: (2022)

AGTRAP Is a Prognostic Biomarker Correlated With Immune Infiltration in Hepatocellular Carcinoma
por: Liu, Shanshan, et al.
Publicado: (2021)

Key Candidate Prognostic Biomarkers Correlated with Immune Infiltration in Hepatocellular Carcinoma
por: Deng, Zenghua, et al.
Publicado: (2021)

LINC00844 promotes proliferation and migration of hepatocellular carcinoma by regulating NDRG1 expression
por: Zhou, Wei, et al.
Publicado: (2020)

Sortilin 1 Promotes Hepatocellular Carcinoma Cell Proliferation and Migration by Regulating Immune Cell Infiltration
por: Gao, Yan, et al.
Publicado: (2022)

Integrative Analysis of the Predictive Value of Perilipin Family on Clinical Significance, Prognosis and Immunotherapy of Glioma
por: Li, Xuanxuan, et al.
Publicado: (2023)

Poor Prognostic Biomarker KIAA1522 Is Associated with Immune Infiltrates in Hepatocellular Carcinoma
por: Shi, Yongjie, et al.
Publicado: (2023)

Pan-cancer analysis suggests histocompatibility minor 13 is an unfavorable prognostic biomarker promoting cell proliferation, migration, and invasion in hepatocellular carcinoma
por: Liu, Jun, et al.
Publicado: (2022)

Prognostic significance of kynurenine 3-monooxygenase and effects on proliferation, migration, and invasion of human hepatocellular carcinoma
por: Jin, Haojie, et al.
Publicado: (2015)

Nucleoporin 107 is a prognostic biomarker in hepatocellular carcinoma associated with immune infiltration
por: Nong, Ju‐sen, et al.
Publicado: (2023)

Serum AP-endonuclease 1 (sAPE1) as novel biomarker for hepatocellular carcinoma
por: Pascut, Devis, et al.
Publicado: (2019)

CDKN2A is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
por: Luo, Jun-peng, et al.
Publicado: (2021)

LMNA functions as an oncogene in hepatocellular carcinoma by regulating the proliferation and migration ability
por: Liu, Heng, et al.
Publicado: (2020)

Prognostic Biomarker DDOST and Its Correlation With Immune Infiltrates in Hepatocellular Carcinoma
por: Zhu, Changyu, et al.
Publicado: (2022)

ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma
por: Wang, Zhen-Zhen, et al.
Publicado: (2022)

Identification of immune-related target and prognostic biomarkers in PBMC of hepatocellular carcinoma
por: Hu, Rui, et al.
Publicado: (2023)

YTH domain family: potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma
por: Liu, Miaomiao, et al.
Publicado: (2021)

METTL5 serves as a diagnostic and prognostic biomarker in hepatocellular carcinoma by influencing the immune microenvironment
por: Wang, Lei, et al.
Publicado: (2023)

The Circular RNA hsa_circ_0001445 Regulates the Proliferation and Migration of Hepatocellular Carcinoma and May Serve as a Diagnostic Biomarker
por: Zhang, Xianwei, et al.
Publicado: (2018)

ZNF165 Is Involved in the Regulation of Immune Microenvironment and Promoting the Proliferation and Migration of Hepatocellular Carcinoma by AhR/CYP1A1
por: Liu, Peng, et al.
Publicado: (2022)

TMEM147 Correlates with Immune Infiltration and Serve as a Potential Prognostic Biomarker in Hepatocellular Carcinoma
por: Cheng, Sheng, et al.
Publicado: (2023)

DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
por: Song, Danjun, et al.
Publicado: (2020)

CCL14 is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma
por: Gu, Yurong, et al.
Publicado: (2020)

EOGT Correlated With Immune Infiltration: A Candidate Prognostic Biomarker for Hepatocellular Carcinoma
por: Shu, Yang, et al.
Publicado: (2022)

BTBD10 is a Prognostic Biomarker Correlated With Immune Infiltration in Hepatocellular Carcinoma
por: Li, Jianhui, et al.
Publicado: (2022)

HSPB11 is a Prognostic Biomarker Associated with Immune Infiltrates in Hepatocellular Carcinoma
por: Liu, Hui, et al.
Publicado: (2022)

Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma
por: Cai, Xiaopeng, et al.
Publicado: (2021)

DDX1 is a prognostic biomarker and correlates with immune infiltrations in hepatocellular carcinoma
por: Yuan, Mengping, et al.
Publicado: (2022)

PVR—A Prognostic Biomarker Correlated with Immune Cell Infiltration in Hepatocellular Carcinoma
por: Liu, Wen-Feng, et al.
Publicado: (2022)

CKLF as a Prognostic Biomarker and Its Association with Immune Infiltration in Hepatocellular Carcinoma
por: Li, Dan, et al.
Publicado: (2023)

CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma
por: Lin, Tong, et al.
Publicado: (2021)

Prognostic stratification based on m(5)C regulators acts as a novel biomarker for immunotherapy in hepatocellular carcinoma
por: Liu, Ping, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_md9o1v978qip1rjetmtf7vrj0l